SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently trading higher as investors react to strong institutional accumulation, a high-profile Nasdaq debut of a key memory supplier, and reports of conditional export approvals for H200 chips in China. The market sentiment is heavily focused on the company's role as the foundation of AI infrastructure, with traders debating whether this momentum represents a sustainable breakout above recent resistance levels or a potential squeeze ahead of upcoming earnings.

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is trending following its major US listing, sparking intense debate among investors over its long-term potential as a key memory supplier for AI infrastructure versus concerns about potential IPO-style volatility. Community members are actively comparing its HBM market dominance and valuation metrics against established domestic semiconductor leaders while debating whether the influx of liquidity will trigger a broader sector rotation or simply validate the ongoing memory supercycle.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF is experiencing heightened volatility as investors weigh robust underlying demand for AI memory against significant technical selling pressure and a complex global rebalancing ahead of a major industry ADR listing. While the community remains divided between those capitalizing on the dip as a long-term value opportunity and others concerned by recent downward price action, conversation is heavily focused on how foreign listing mechanics and institutional positioning are driving current market movements.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending as traders debate the market's resilience against persistent geopolitical tensions in the Middle East and concerns over slowing AI capital expenditure. The community remains sharply divided between bulls banking on continued rotation into growth tech and bears expecting a broader market correction driven by high valuations and geopolitical instability.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors weigh the stock's long-term growth potential in LNG exports against ongoing geopolitical volatility in the Strait of Hormuz. The community is actively debating the company's valuation relative to its aggressive production targets, with many focusing on the impact of regional conflict on supply chains versus the fundamental tailwinds of global energy demand.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is experiencing heightened volatility and intense community debate as market participants weigh renewed geopolitical tensions in the Strait of Hormuz against upcoming earnings reports and economic data. Investors remain divided, with many actively monitoring futures for direction while debating whether the market's recent resilience signifies a true bull trend or a vulnerable position prone to a sharp reversal.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares (LABU) is trending as traders analyze aggressive institutional accumulation in biotech and the sector's breakout potential following significant M&A activity. Community discussion is focused on the impact of shifting rate expectations, institutional inflows into related ETFs, and the technical setup as the biotech sector tests key resistance levels amid broader market rotation.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing significant community debate as investors weigh the company's long-term potential in AI infrastructure and power capacity against concerns over founder compensation and ongoing share dilution. While some traders are closely watching critical support levels and technical chart setups for a potential recovery, sentiment remains divided between those capitalizing on dip-buying opportunities and those skeptical of management's recent capital allocation decisions.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility as investors navigate aggressive rebalancing by the Korean National Pension Service and a broader unwind of crowded semiconductor trades. Community discussion is sharply divided between those viewing the pullback as a technical entry opportunity ahead of upcoming domestic IPOs and those bracing for further downside from leveraged position liquidations.

ETF Opportunities Trust - Roundhill T-REX 2X Long DRAM Daily Target ETF

T-REX 2X Long DRAM Daily Target ETF

RAM is experiencing significant trading activity following its recent debut as a leveraged 2X bull ETF designed to track the DRAM memory sector, capturing the immediate momentum from strong earnings in the semiconductor space. The community is actively debating the product's high-beta risk and volatility, with participants polarized between those betting on an extended AI memory supercycle and others warning of the dangers inherent in holding leveraged instruments during sector pullbacks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CMPS Stock Clocks Muted Gains But Analysts Back Psychedelic Drug’s Durability Ahead Of FDA Filing

Equity

Multiple analysts reiterated optimism on CMPS stock after the company announced 26-week data from its second late-stage trial of COMP360 in treatment-resistant depression.


Best ETF Areas of June

Biotech, China, insurance and healthcare ETFs led June gains as strong earnings, AI optimism and easing geopolitical fears lifted markets.

ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise

Absci Corporation said that its drug ABS-201 was well-tolerated and showed a long-lasting presence in the body in a clinical trial.


Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead?

Biotech ETFs are surging in 2026 as a friendlier FDA, strong M&A activity and AI-driven drug discovery fuel optimism for more upside.

Cathie Wood's ARK Bets Bigger On This Biotech Play, Slashes Stake In This Space Stock 

ARK Investment Management bought shares worth more than $3.5 million of Intellia Therapeutics and sold shares of Rocket Lab worth more than $4 million on Monday. 

CMPS On Track For Best Week Ever On FDA Push For Psychedelics

Compass said on Friday that the FDA has granted its synthetic psilocybin formulation the Commissioner's National Priority Voucher for treatment-resistant depression.


Tempus AI Stock Near 1-Year Low: Cathie Wood’s ARK Buys More While Offloading Nvidia, Meta, Other Tech Plays

Tempus AI was the only stock purchased by ARK Innovation ETF (ARKK) in the latest session, signaling targeted conviction.

Why Is CRSP Stock Falling Pre-Market Today?

The company plans to issue $350 million in convertible senior notes that are scheduled to mature in 2031.


RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’

Recursion reported a loss of $0.21 per share on revenue of $35.5 million, compared to Wall Street estimates of a loss of $0.32 per share on revenue of $24.6 million, according to Koyfin.

CMPS Stock Rises 23% Pre-Market As Compass Achieves Primary Endpoint In Phase 3 Treatment-Resistant Depression Trial

The company is currently conducting clinical trials of COMP360, a proprietary synthetic formulation of psilocybin, designed for treatment-resistant depression.

ARK ETF Trust - ARK Genomic Revolution ETF

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

ARKGARK Investment Management LLC - ARK Genomic Revolution ETF

Latest ARKG News